MedTrace Logo

Laxative Properties of Microencapsulated Lipid (Constipation Study)

NCT05324241 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-05-31

No results posted yet for this study

Summary

The present study seeks to build on these observations to assess whether in principle, fat containing microcapsules might help patients experiencing constipation in association with weight loss interventions (including GLP-1 analogues or bariatric surgery) to both avoid/treat constipation and simultaneously optimise their ability to feel full during eating. This potential dual action may provide added benefit versus the use of traditional approaches to constipation prophylaxis e.g., lactulose.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fat Microcapsules

Consumption of a drink that contains microencapsulated fat that will be released either in the stomach or in the distal small intestines.

Sponsors & Collaborators

  • University College Dublin

    lead OTHER

Principal Investigators

  • Carel le Roux · University College Dublin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2023-04-15
Completion
2023-04-15

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05324241 on ClinicalTrials.gov